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Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in
general practice
Abstract
Objectives: To compare the clinical diagnosis of chronic obstructive pulmonary disease (COPD) with
results of post-bronchodilator spirometry in general practice, and examine practitioner, practice and
patient characteristics associated with agreement between clinical and spirometric diagnoses. Design,
setting and participants: General practitioners from practices in Sydney identified eligible patients aged
40-80 years seen in the past year and prescribed respiratory medications whom they regarded as having
COPD. Between November 2006 and April 2008, we collected information on the GPs and their practices,
and demographic information, smoking status, comorbidities, respiratory medicines use, vaccination
status, quality of life and spirometry results for participating patients. Main outcome measures:
Frequency of COPD diagnosis on spirometry; odds ratios for characteristics associated with agreement
between clinical and spirometric diagnoses. Results: 56 GPs from 44 practices participated in the study.
Of 1144 eligible patients, 445 were recruited (mean age, 65 years; 49% male). Of these, 257 (57.8%) had
post-bronchodilator spirometry consistent with COPD ± asthma, 16 (3.6%) had asthma only, 82 (18.4%)
had normal spirometry, and 90 (20.2%) had other spirometric diagnoses. Having a spirometer in the
practice was not predictive of agreement between clinical and spirometric diagnoses. Older patient age
was significantly associated with correct diagnosis, while higher numbers of comorbidities were
associated with misdiagnosis. Conclusions: A substantial proportion of patients clinically identified as
having COPD in general practice do not have the condition according to spirometric criteria, with
inaccurate diagnosis more common in patients with comorbidities. Policy and practice change is needed
to support the use of spirometry in primary care.
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Predictors of accuracy of diagnosis of chronic obstructive
pulmonary disease in general practice
Nicholas A Zwar, Guy B Marks, Oshana Hermiz, Sandy Middleton,
Elizabeth J Comino, Iqbal Hasan, Sanjyot Vagholkar and Stephen F Wilson
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hronic obstructive pulmonary disease
(COPD) is a major cause of mortality,
morbidity and health service use,
including hospitalisation. It is the seventh
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managed
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rate
of 21 per 100
encounters with patients in this age group,3
making it a common problem in older people.
Both international4 and Australian5 clinical practice guidelines for COPD state that
its diagnosis rests on the demonstration of
airflow obstruction that is not fully reversible. Spirometry is therefore essential for
accurate diagnosis of COPD. Although
there is evidence that office spirometry
improves early detection of COPD in general practice, and despite the majority of
general practices in Australia owning a
spirometer,6 it is infrequently used in primary care in Australia and internationally,
and the diagnosis is usually made on clinical grounds.7-9 Several studies in primary
care settings have demonstrated inaccuracy
of COPD clinical diagnosis compared with
spirometric diagnosis.10-13
We know little about the practitioner,
practice and patient factors that influence the
accuracy of the diagnosis of COPD in general
practice in Australia or comparable countries. Understanding these factors could be of
use in developing and targeting interventions
aimed at improving COPD diagnosis. As part
of the baseline assessment for an intervention study involving patients considered by
their GPs to have COPD, we examined the
accuracy of the GPs’ diagnoses in relation to
the gold standard of spirometric diagnosis.
We also examined practitioner, practice and
patient factors that predicted agreement
between the diagnostic label and the finding
of post-bronchodilator airflow obstruction.
METHODS
This study was done in the context of a
randomised controlled trial of a nurse-based
168

ABSTRACT
Objectives: To compare the clinical diagnosis of chronic obstructive pulmonary disease
(COPD) with results of post-bronchodilator spirometry in general practice, and examine
practitioner, practice and patient characteristics associated with agreement between
clinical and spirometric diagnoses.
Design, setting and participants: General practitioners from practices in Sydney
identified eligible patients aged 40–80 years seen in the past year and prescribed
respiratory medications whom they regarded as having COPD. Between November
2006 and April 2008, we collected information on the GPs and their practices, and
demographic information, smoking status, comorbidities, respiratory medicines use,
vaccination status, quality of life and spirometry results for participating patients.
Main outcome measures: Frequency of COPD diagnosis on spirometry; odds ratios for
characteristics associated with agreement between clinical and spirometric diagnoses.
Results: 56 GPs from 44 practices participated in the study. Of 1144 eligible patients,
445 were recruited (mean age, 65 years; 49% male). Of these, 257 (57.8%) had postbronchodilator spirometry consistent with COPD ± asthma, 16 (3.6%) had asthma only, 82
(18.4%) had normal spirometry, and 90 (20.2%) had other spirometric diagnoses. Having
a spirometer in the practice was not predictive of agreement between clinical and
spirometric diagnoses. Older patient age was significantly associated with correct
diagnosis, while higher numbers of comorbidities were associated with misdiagnosis.
Conclusions: A substantial proportion of patients clinically identified as having COPD in
general practice do not have the condition according to spirometric criteria, with
inaccurate diagnosis more common in patients with comorbidities. Policy and practice
change is needed to support the use of spirometry in primary care.
MJA 2011; 195: 168–171

intervention to improve COPD management. The data are from the cross-sectional
baseline assessment conducted for this trial
between November 2006 and April 2008.
Ethics approval was granted by the University of New South Wales Human Research
Ethics Committee.
Study population and data collection
The protocol of the trial has been published
elsewhere.14 In brief, GPs were recruited
from a list of 256 GPs from practices in
south-western Sydney who had previously
taken part in research or who attended
continuing medical education events held
by local Divisions of General Practice. GPs
on the list were approached by mail, followed by a telephone call from one of the
investigators (N A Z or S V). If GPs expressed
interest, a member of the project team
(N A Z, S V or O H) visited the practice to
explain the study and gain informed consent
from the GP(s) involved. At this visit, GPs
MJA • Volume 195 Number 4 • 15 August 2011

were asked to complete a questionnaire that
covered characteristics of themselves and
their practices. The practitioner characteristics were age, sex, vocational registration
status, local or overseas graduate, and years
in practice. Practice characteristics collected
were practice accreditation status, presence
of a spirometer in the practice, presence of a
practice nurse, presence of a practice manager, and whether it was a solo or a group
practice.
Participating GPs were asked to search
their electronic prescription records to identify patients who had been prescribed medications used for COPD, defined as inhaled
β2 agonists, inhaled corticosteroids, ipratropium bromide, tiotropium, oral theophylline and oral corticosteroids. Patients were
eligible if they were aged between 40 and 80
years, had been prescribed one or more of
these medications, and had seen the GP in
the previous 12 months. GPs were asked to
manually review the list generated and iden-
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tify those patients they considered to have a
diagnosis of COPD, emphysema or chronic
bronchitis, including those they considered
to have coexisting problems, such as
asthma. GPs were asked to include all eligible patients regardless of how or where the
diagnosis had been made; information on
how the diagnosis was made was not collected. GPs were asked to exclude patients if
they considered they did not speak English
or had significant cognitive impairment.
The project officers (O H and I H) recruited
the identified subjects, with consent, into the
trial and gathered data during a home visit.
Patient characteristics recorded were age, sex,
number of comorbidities, whether born in
Australia or overseas, respiratory medicines
used, vaccination status, quality of life
(assessed using the St George’s Respiratory
Questionnaire and the 12-item Short Form
Health Survey), and smoking status.
Spirometry procedure
The patient assessment included pre- and
post-bronchodilator spirometry using an
EasyOne spirometer (ndd Medical Technologies, Andover, Mass, USA), performed by
one of two project officers from medical
backgrounds (O H and I H) who had been
trained in spirometry at the respiratory

in FEV1 after bronchodilator ⭓ 200 mL
AND ⭓ 12% of baseline. COPD and
asthma labels were not mutually exclusive.

function laboratory at Liverpool Hospital in
Sydney. Patients were instructed not to take
short-acting β2 agonists for at least 4 hours
before the test, or long-acting β2 agonists,
ipratropium bromide or tiotropium for at
least 12 hours before the test. Post-bronchodilator spirometry was performed
between 10 and 15 minutes after 400 μg of
salbutamol was delivered via a metered dose
inhaler. Three forced expirations were
attempted before and after bronchodilator
administration, and the spirometer’s
firmware algorithm was used to select best
forced expiratory volume in 1 second
(FEV1) and best forced vital capacity (FVC),
using American Thoracic Society (ATS) criteria.15 The patients’ results were compared
with the third National Health and Nutrition
Examination Survey reference values for
predicted FEV1 values.16
Patients were defined as having COPD if
they had a post-bronchodilator FEV1/FVC
ratio < 0.7. Severity of COPD was classified
using the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) stages,
from Stage 1 (mild) to Stage 4 (very
severe).4 Normal spirometry was defined as
a pre-bronchodilator FEV1/FVC ratio ⭓ 0.7
AND a pre-bronchodilator FEV1 ⭓ 80%
predicted. Asthma was defined as a change

Statistical analysis
Baseline characteristics were described as
means or frequencies for each patient category, adjusted for clustering at the GP level
using the SAS procedures SURVEYMEANS
and SURVEYFREQ (SAS 9.2; SAS Institute,
Cary, NC, USA). Univariate P values for
comparisons of means and frequencies
between the groups who did and did not
have a post-bronchodilator FEV1/FVC ratio
< 0.7 were calculated and adjusted for clustering at the GP level using mixed regression
and PROC SURVEYFREQ.
The independent effect of each practitioner, practice and patient characteristic on
the probability of agreement between clinical diagnosis and post-bronchodilator FEV1/
FVC ratio < 0.7 was estimated using a generalised linear mixed model implemented in
the SAS procedure PROC GLIMMIX. This
procedure adjusts for clustering at the GP
level. We estimated odds ratios using a
logistic link and binary error structure. Collinearity among the covariates was tested for
and found not to be present. P < 0.05 was
considered significant.

1 Characteristics of 445 participating patients, by spirometric diagnosis
Non-COPD diagnoses
COPD ± asthma
(n = 257)

No COPD
(n = 188)

67.1 (9.7)

62.2 (10.5)

64.0 (8.0)

Male

134 (52.1%)

82 (43.6%)

Current smoker

83 (32.3%)

52 (27.7%)

Australian-born

109 (42.4%)

Other*
(n = 90)

P†

60.2 (10.1)

63.8 (11.0)

0.08

6 (37.5%)

29 (35.4%)

47 (52.2%)

0.06

5 (31.3%)

26 (31.7%)

21 (23.3%)

0.30

90 (47.9%)

11 (68.8%)

42 (51.2%)

51 (56.7%)

0.27

3.6 (2.1)

4.3 (2.5)

3.7 (2.3)

4.0 (2.6)

4.6 (2.3)

0.05

Used at least one respiratory medication

234 (91.1%)

144 (76.6%)

15 (93.8%)

59 (72.0%)

72 (80.0%)

< 0.001

Used tiotropium

144 (56.0%)

57 (30.3%)

7 (43.8%)

17 (20.7%)

33 (36.7%)

< 0.001

Used at least one long-acting bronchodilator

211 (82.1%)

118 (62.8%)

14 (87.5%)

45 (54.9%)

59 (65.6%)

0.03

Used inhaled corticosteroids

169 (65.8%)

94 (50.0%)

12 (75.0%)

34 (41.5%)

48 (53.3%)

0.001
0.33

Mean age (SD)

Mean number of comorbidities (SD)

Mean COPD knowledge score (SD)

Asthma only Normal spirometry
(n = 16)
(n = 82)

8.8 (1.5)

9.0 (1.3)

9.2 (1.3)

8.9 (1.5)

9.0 (1.2)

Influenza vaccination

186 (72.4%)

120 (63.8%)

8 (50.0%)

47 (57.3%)

65 (72.2%)

0.05

Pneumococcal vaccination

167 (65.0%)

89 (47.3%)

5 (31.3%)

37 (45.1%)

47 (52.2%)

< 0.001

24 (9.3%)

5 (2.7%)

0

1 (1.2%)

4 (4.4%)

Attended pulmonary rehabilitation

0.005

Mean SGRQ overall score (SD)

44.5 (17.5)

38.3 (20.0)

41.8 (19.3)

32.2 (20.3)

43.1 (18.6)

0.01

Mean SGRQ symptoms score (SD)

53.7 (20.6)

47.1 (22.9)

56.2 (28.8)

41.7 (22.0)

50.4 (21.6)

0.002

Mean SF-12 PCS score (SD)

35.6 (11.0)

38.1 (12.7)

35.6 (11.1)

40.9 (12.8)

35.9 (11.8)

0.01

Mean SF-12 MCS score (SD)

49.7 (11.6)

48.4 (11.6)

46.0 (12.3)

48.8 (11.3)

48.6 (11.9)

0.78

Hospital attendance for respiratory condition

10 (3.9%)

4 (2.1%)

0

2 (2.4%)

2 (2.2%)

0.25

COPD = chronic obstructive pulmonary disease. SGRQ = St George’s Respiratory Questionnaire. SF-12 = 12-item Short Form Health Survey. PCS = Physical Component
Summary. MCS = Mental Component Summary. * Such as restriction. † P value is for the difference between COPD and no COPD.
◆
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RESULTS
Fifty-six GPs from 44 general practices in
Sydney participated in the study. The mean
age of GPs was 52.3 years, and 47 were
male. Of the 56 GPs, 51 were vocationally
registered (recognised as having specialty
qualification in general practice), 30 were
graduates of an Australian or New Zealand
university, and they had a mean of 15.6
years’ (range, 1–35) experience in practice.
Forty-seven of the GPs worked in accredited
practices, 40 had a spirometer in the practice, 25 had a practice nurse and 45 had a
practice manager.
The record search and review of the list
generated by the GPs identified 1144
patients who were eligible and invited to
participate. Of these, 445 patients (38.9%)
were recruited and provided baseline data.
The mean age of participants was 65.0 years,
and 217 (48.8%) were male. The mean
number of comorbidities was 3.9 (range, 0–
14). More than half (55.1%; 244/443) were
born in Australia, and 30.5% (134/440)
were current smokers.
Of the 445 patients, 257 (57.8%) had
post-bronchodilator spirometry showing
COPD with or without asthma, 16 (3.6%)
had asthma only, 82 (18.4%) had normal
spirometry, and 90 (20.2%) had other spirometric diagnoses such as restriction. Of the
patients with COPD, 33 (12.8%) had GOLD
Stage 1, 118 (45.9%) had Stage 2, 79
(30.7%) had Stage 3 and 27 (10.5%) had
Stage 4, by post-bronchodilator spirometry.
The characteristics of all participating
patients are shown in Box 1 by spirometric
diagnosis. Patients who had COPD on
spirometry tended to be older, male and
have fewer comorbidities. There were significant differences between those with and
those without COPD in terms of treatment
received, disease-related quality of life and
overall quality of life.
The associations between practitioner,
practice and patient factors and having airflow obstruction on spirometry are shown in
Box 2. There were three statistically significant associations. Having a practice manager
in the general practice was associated with a
higher chance of misdiagnosis. Older
patients were more likely to be correctly
diagnosed, and those with higher numbers
of comorbidities were less likely to be correctly diagnosed.
DISCUSSION
We found that there are substantial rates of
misdiagnosis of COPD in primary care, with
170

2 Predictors of agreement between
clinical diagnosis of COPD and
post-bronchodilator airflow
obstruction on spirometry (n = 445)
Characteristic

OR (95% CI)

P

Male

0.76 (0.25–2.30)

0.63

Vocationally
registered

1.36 (0.16–11.69)

0.78

Overseas
graduate

0.79 (0.40–1.53)

0.49

Accredited

1.58 (0.54–4.66)

0.40

Spirometer

1.80 (0.79–4.08)

0.16

Nurse

1.02 (0.47–2.19)

0.96

Manager

0.37 (0.15–0.90)

0.03

Solo practice

1.14 (0.43–3.00)

0.79

Older age

1.86 (1.42–2.44)

< 0.001

Male

1.33 (0.82–2.17)

0.25

Australianborn

1.34 (0.81–2.22)

0.26

Higher no. of
comorbidities

0.83 (0.74–0.93)

0.002

Non-smoker

0.65 (0.38–1.13)

0.13

Practitioner

Practice

Patient

COPD = chronic obstructive pulmonary disease.
OR = odds ratio.

◆

less than 60% of patients having the clinical
diagnosis confirmed on spirometry. This has
important implications for management,
including using medicines to treat COPD in
patients who do not have the condition. In
this study, 57 of the 188 patients who did
not have COPD on spirometry were being
treated with tiotropium. This exposes
patients to unnecessary risk of adverse
effects of medications and has cost implications for the patients and the health system.
It also means that the true cause of a
patient’s respiratory symptoms may not be
correctly identified and treated.
Our findings confirm those from previous
studies in primary care. In a study in Greece
of 319 patients aged over 40 years diagnosed as having COPD, 50% had a postbronchodilator FEV1/FVC ratio < 0.7.10 A
similar rate was found in a study in primary
care practices in Scotland and the United
States,11 where 48% of patients with a prior
diagnosis of chronic bronchitis or emphysema were confirmed as having COPD on
post-bronchodilator spirometry. In a study
of 580 patients on a general practice-based
COPD register in England,12 79% had
obstruction on pre-bronchodilator spiromeMJA • Volume 195 Number 4 • 15 August 2011

try. Reversibility testing was not done for all
patients in that study, so this may be an
overestimate of the prevalence of COPD. In
a Canadian study, where spirometry was
more often used in clinical practice, the rate
of misclassification was lower (12% of
patients aged over 40 years).13
Our study adds to previous research in
that we looked for characteristics of practitioners, their practices and patients that are
associated with diagnostic accuracy. The
striking finding is that presence of a spirometer in the practice was not associated
with diagnostic accuracy. It may be that
spirometers are not being used because of
time limitations or lack of adequate financial
reward, or that there are problems with the
quality of spirometry performed in general
practice. Qualitative research in Tasmania
found that GPs preferred to diagnose COPD
on clinical grounds and there were both
organisational and technical barriers to
greater use of spirometry.7 A study in the
United Kingdom found that, despite incentives to perform spirometry, lack of adequate
training in its use and interpretation meant
that diagnosis was more likely to be made
on clinical grounds.17
The only practice factor significantly (and
negatively) associated with diagnostic accuracy was the presence of a practice manager.
We are unable to explain this, as practice
managers have no role in the diagnostic
process, and believe it must be a chance
finding. Although practice managers were
more likely to be working in larger practices,
which are in turn likely to have more doctors in training, this is unlikely to explain
the association as there was no difference
found in diagnostic accuracy between solo
and group practices.
The other important finding was that
presence of comorbidities was significantly
associated with diagnostic inaccuracy. As
accurate spirometry should be possible
despite comorbidities, this has implications
for practice as it suggests that patients with
comorbidities should be prioritised for thorough investigation. Older age was associated
with higher diagnostic accuracy, presumably
due to increased prevalence of COPD with
age.
A recent study found that the likelihood
of misclassification increased with overweight or obesity and self-reported allergic
rhinitis or hayfever,18 but did not report a
relationship with the number of comorbidities. Consistent with our study, it found
decreased likelihood of misclassification
with increasing age.18 The investigators did
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not examine for practice and practitioner
factors associated with misclassification.
A limitation of our study is that we did
not have information on how the diagnosis
of COPD was made in the patients. It could
be that patients had been diagnosed on the
basis of clinical features and had not had
spirometry, particularly as there are barriers
to the use of spirometry in primary care.
Another possibility is that the spirometry
done by the treating clinicians or by the
study team was incorrect or involved poor
patient technique. We are confident in the
quality of the spirometry done for the study
as the project officers had substantial training and expert oversight. The ATS criteria
that require three acceptable expirations
were achieved for the patients in our study,
so poor technique was not a factor.
While it was possible to withhold treatment with bronchodilators before spirometry, it was not possible to withdraw inhaled
corticosteroids, and some patients treated
with these medicines may have met the
criteria for COPD if they had not been
using this treatment. Similarly, tiotropium
was not withheld for 24 hours or more in
every patient, so it is possible that a small
number of patients with mild obstruction
when not being treated may have had
normal spirometry.
Until an alternative to spirometry is
found, there is a need to develop and evaluate strategies to encourage its use and
improve its quality in the diagnostic process
of patients seen in general practice. A policy
issue is the low level of remuneration
received for performing spirometry (the current Medicare rebate is $16.85 for pre- and
post-bronchodilator spirometry). Another
issue is the availability of appropriately
trained workforce to perform spirometry in
primary care. Up-skilling of practice nurses
is an option, as there is evidence that nurses
can take on this role,19-21 but training and
quality assurance are needed, along with
adequate funding.9
An approach arising from this study could
be to prioritise patients with comorbidities
for thorough diagnostic assessment, including spirometry, as this group may be more
likely to be incorrectly diagnosed. As demonstrated in research in Tasmania,22 patients
are presenting to their GPs with respiratory
symptoms, but a substantial number do not
have either COPD or asthma. Thus, there is
also a need to better understand the nature
and causes of respiratory symptoms in
patients in general practice.
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